SCHEMBL8375774

SCHEMBL8375774

CC[CH]c1c(I)ccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.42
ALDH1A1 P00352 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP2A6 P11509 3/20 0.42
L3MBTL1 Q9Y468 4/20 0.41
GAA P10253 2/20 0.41
ERN1 O75460 1/20 0.40
HPRT1 P00492 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 5/20 0.38
CYP1A2 P05177 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18242152 0.82 CYP2A6 (0.44) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL9466601 0.82 ALDH1A1 (0.44) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL1706021 0.80 CYP1A2 (0.52) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL7254708 0.78 ERN1 (0.60) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL1613222 0.77 NR1I2 (0.47) TSHRALDH1A1HSD17B10CYP2A6L3MBTL1
SCHEMBL8375753 0.76 KDM4E (0.61) ALDH1A1TDP1L3MBTL1GAANPC1
SCHEMBL5010129 0.76 L3MBTL1 (0.39) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL5010151 0.73 CYP2A6 (0.42) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL5008784 0.72 DNMT1 (0.38) TSHRALDH1A1TDP1HSD17B10CYP2A6
SCHEMBL7801282 0.72 ALDH1A1 (0.51) TSHRALDH1A1TDP1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed